Clinical outcomes among ErbB2+MBC patients treated with lapatinib-capecitabine after trastuzumab progression: Role of early switch to lapatinib (TYCO study).

---

ABULKHAIR O., USLU R., SEZGIN C., BUEYUEKBERBER S., DARWISH T., ISIKDOGAN A., ...More

CANCER RESEARCH, vol.72, 2012 (Peer-Reviewed Journal)

• Publication Type: Article / Abstract
• Volume: 72
• Publication Date: 2012
• Doi Number: 10.1158/0008-5472.sabcs12-ot1-1-08
• Journal Name: CANCER RESEARCH
• Journal Indexes: Science Citation Index Expanded, Scopus